• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维生素 D3 传递用醇质体和转醇质体的配方研究及细胞内命运评估。

Formulative Study and Intracellular Fate Evaluation of Ethosomes and Transethosomes for Vitamin D3 Delivery.

机构信息

Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, I-37134 Verona, Italy.

Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, I-44121 Ferrara, Italy.

出版信息

Int J Mol Sci. 2021 May 19;22(10):5341. doi: 10.3390/ijms22105341.

DOI:10.3390/ijms22105341
PMID:34069489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8161393/
Abstract

In this pilot study, ethosomes and transethosomes were investigated as potential delivery systems for cholecalciferol (vitamin D3), whose deficiency has been correlated to many disorders such as dermatological diseases, systemic infections, cancer and sarcopenia. A formulative study on the influence of pharmaceutically acceptable ionic and non-ionic surfactants allowed the preparation of different transethosomes. In vitro cytotoxicity was evaluated in different cell types representative of epithelial, connective and muscle tissue. Then, the selected nanocarriers were further investigated at light and transmission electron microscopy to evaluate their uptake and intracellular fate. Both ethosomes and transethosomes proven to have physicochemical properties optimal for transdermal penetration and efficient vitamin D3 loading; moreover, nanocarriers were easily internalized by all cell types, although they followed distinct intracellular fates: ethosomes persisted for long times inside the cytoplasm, without inducing subcellular alteration, while transethosomes underwent rapid degradation giving rise to an intracellular accumulation of lipids. These basic results provide a solid scientific background to in vivo investigations aimed at exploring the efficacy of vitamin D3 transdermal administration in different experimental and pathological conditions.

摘要

在这项初步研究中,我们研究了醇质体和转醇质体作为胆钙化醇(维生素 D3)的潜在传递系统,维生素 D3 的缺乏与许多疾病有关,如皮肤病、全身感染、癌症和肌肉减少症。通过对药用可接受的离子型和非离子型表面活性剂的制剂研究,我们制备了不同的转醇质体。在体外,我们在不同的细胞类型中评估了细胞毒性,这些细胞类型代表了上皮、结缔和肌肉组织。然后,我们进一步用光镜和透射电子显微镜研究了选定的纳米载体,以评估它们的摄取和细胞内命运。醇质体和转醇质体都被证明具有最佳的物理化学性质,可促进透皮渗透和高效负载维生素 D3;此外,纳米载体很容易被所有细胞类型内化,尽管它们遵循不同的细胞内命运:醇质体在细胞质中长时间存在,不会引起亚细胞改变,而转醇质体则迅速降解,导致细胞内脂质积累。这些基础结果为探索不同实验和病理条件下维生素 D3 经皮给药疗效的体内研究提供了坚实的科学基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10e2/8161393/9ce7fe0870cd/ijms-22-05341-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10e2/8161393/8b908aa74ade/ijms-22-05341-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10e2/8161393/4a8d716d2648/ijms-22-05341-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10e2/8161393/46dee1c80c6e/ijms-22-05341-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10e2/8161393/b6f8aa265faa/ijms-22-05341-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10e2/8161393/f8a37b36fe54/ijms-22-05341-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10e2/8161393/964655a63e61/ijms-22-05341-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10e2/8161393/5170381943a7/ijms-22-05341-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10e2/8161393/9ce7fe0870cd/ijms-22-05341-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10e2/8161393/8b908aa74ade/ijms-22-05341-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10e2/8161393/4a8d716d2648/ijms-22-05341-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10e2/8161393/46dee1c80c6e/ijms-22-05341-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10e2/8161393/b6f8aa265faa/ijms-22-05341-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10e2/8161393/f8a37b36fe54/ijms-22-05341-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10e2/8161393/964655a63e61/ijms-22-05341-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10e2/8161393/5170381943a7/ijms-22-05341-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10e2/8161393/9ce7fe0870cd/ijms-22-05341-g008.jpg

相似文献

1
Formulative Study and Intracellular Fate Evaluation of Ethosomes and Transethosomes for Vitamin D3 Delivery.维生素 D3 传递用醇质体和转醇质体的配方研究及细胞内命运评估。
Int J Mol Sci. 2021 May 19;22(10):5341. doi: 10.3390/ijms22105341.
2
Development, characterization, and skin delivery studies of related ultradeformable vesicles: transfersomes, ethosomes, and transethosomes.相关超可变形囊泡(传递体、醇质体和转醇质体)的开发、表征及皮肤给药研究。
Int J Nanomedicine. 2015 Sep 18;10:5837-51. doi: 10.2147/IJN.S86186. eCollection 2015.
3
Ex Vivo Evaluation of Ethosomes and Transethosomes Applied on Human Skin: A Comparative Study.经皮给药系统中醇质体和传递体的离体评价:一项比较研究。
Int J Mol Sci. 2022 Dec 1;23(23):15112. doi: 10.3390/ijms232315112.
4
Dimethyl Fumarate-Loaded Transethosomes: A Formulative Study and Preliminary Ex Vivo and In Vivo Evaluation.富马酸二甲酯载转质体的制剂研究及初步的离体和在体评价。
Int J Mol Sci. 2022 Aug 6;23(15):8756. doi: 10.3390/ijms23158756.
5
Development of nanovesicular systems for dermal imiquimod delivery: physicochemical characterization and in vitro/in vivo evaluation.用于咪喹莫特经皮递送的纳米囊泡系统的开发:物理化学表征及体外/体内评价
J Mater Sci Mater Med. 2015 Jun;26(6):191. doi: 10.1007/s10856-015-5524-1. Epub 2015 May 20.
6
Ethosomes and Transethosomes for Mangiferin Transdermal Delivery.用于芒果苷透皮给药的乙醇脂质体和转乙醇脂质体
Antioxidants (Basel). 2021 May 12;10(5):768. doi: 10.3390/antiox10050768.
7
Ethosomal nanocarriers: the impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials.乙醇胺纳米载体:成分和制剂技术对乙醇胺纳米粒性质、体内研究及临床试验的影响
Int J Nanomedicine. 2016 May 25;11:2279-304. doi: 10.2147/IJN.S105016. eCollection 2016.
8
Evaluation of paeonol-loaded transethosomes as transdermal delivery carriers.载丹皮酚传递体作为透皮给药载体的评价
Eur J Pharm Sci. 2017 Mar 1;99:240-245. doi: 10.1016/j.ejps.2016.12.026. Epub 2016 Dec 28.
9
Combinations of nanovesicles and physical methods for enhanced transdermal delivery of a model hydrophilic drug.纳米囊泡与物理方法联合增强模型亲水性药物的透皮递送。
Eur J Pharm Biopharm. 2018 Jun;127:387-397. doi: 10.1016/j.ejpb.2018.03.008. Epub 2018 Mar 23.
10
Ethosomes as Vesicles for Effective Transdermal Delivery: From Bench to Clinical Implementation.作为有效透皮给药载体的醇质体:从实验室到临床应用
Curr Clin Pharmacol. 2016;11(3):168-190. doi: 10.2174/1574884711666160813231352.

引用本文的文献

1
Nanovesicles and Human Skin Interaction: A Comparative Ex-Vivo Study.纳米囊泡与人体皮肤的相互作用:一项比较性体外研究。
Nanomaterials (Basel). 2025 Jun 16;15(12):937. doi: 10.3390/nano15120937.
2
QbD-Anchored Preparation and Assessment of Transethosomal Gel for Enhanced Skin Permeation of Tamoxifen Citrate.基于质量源于设计的柠檬酸他莫昔芬经皮传递体凝胶的制备与评价,以增强其皮肤渗透性能
Curr Pharm Des. 2025;31(29):2352-2369. doi: 10.2174/0113816128344198250308022732.
3
Cellular Uptake and Trafficking of Lipid Nanocarriers Using High-Resolution Electron Microscopy.

本文引用的文献

1
Vitamin D and Sarcopenia: Potential of Vitamin D Supplementation in Sarcopenia Prevention and Treatment.维生素 D 与肌肉减少症:维生素 D 补充在肌肉减少症预防和治疗中的潜力。
Nutrients. 2020 Oct 19;12(10):3189. doi: 10.3390/nu12103189.
2
Design and Characterization of Ethosomes for Transdermal Delivery of Caffeic Acid.用于咖啡酸透皮递送的醇质体的设计与表征
Pharmaceutics. 2020 Aug 6;12(8):740. doi: 10.3390/pharmaceutics12080740.
3
Ethosomes for Coenzyme Q10 Cutaneous Administration: From Design to 3D Skin Tissue Evaluation.用于辅酶Q10经皮给药的醇质体:从设计到3D皮肤组织评估
利用高分辨率电子显微镜研究脂质纳米载体的细胞摄取与转运
AAPS PharmSciTech. 2025 Feb 26;26(3):71. doi: 10.1208/s12249-025-03061-3.
4
Enhanced Anti-Melanoma Activity of Nutlin-3a Delivered via Ethosomes: Targeting p53-Mediated Apoptosis in HT144 Cells.通过醇质体传递 Nutlin-3a 增强抗黑色素瘤活性:靶向 HT144 细胞中 p53 介导的细胞凋亡。
Cells. 2024 Oct 11;13(20):1678. doi: 10.3390/cells13201678.
5
Recent Advancements and Trends of Topical Drug Delivery Systems in Psoriasis: A Review and Bibliometric Analysis.近年来银屑病局部给药系统的研究进展及趋势:综述和文献计量分析。
Int J Nanomedicine. 2024 Jul 29;19:7631-7671. doi: 10.2147/IJN.S461514. eCollection 2024.
6
Characterization Methods for Nanoparticle-Skin Interactions: An Overview.纳米颗粒与皮肤相互作用的表征方法:综述
Life (Basel). 2024 May 8;14(5):599. doi: 10.3390/life14050599.
7
Metformin HCl-loaded transethosomal gel; development, characterization, and antidiabetic potential evaluation in the diabetes-induced rat model.盐酸二甲双胍负载传递体凝胶的研制、表征及在糖尿病大鼠模型中的抗糖尿病作用评价。
Drug Deliv. 2023 Dec;30(1):2251720. doi: 10.1080/10717544.2023.2251720.
8
Ginger Extract-Loaded Transethosomes for Effective Transdermal Permeation and Anti-Inflammation in Rat Model.姜提取物负载传递体用于大鼠模型中的有效透皮渗透和抗炎作用。
Int J Nanomedicine. 2023 Mar 15;18:1259-1280. doi: 10.2147/IJN.S400604. eCollection 2023.
9
An ex vivo experimental system to track fluorescent nanoparticles inside skeletal muscle.一种用于追踪骨骼肌内荧光纳米粒子的离体实验系统。
Eur J Histochem. 2023 Jan 2;67(1):3596. doi: 10.4081/ejh.2023.3596.
10
Ex Vivo Evaluation of Ethosomes and Transethosomes Applied on Human Skin: A Comparative Study.经皮给药系统中醇质体和传递体的离体评价:一项比较研究。
Int J Mol Sci. 2022 Dec 1;23(23):15112. doi: 10.3390/ijms232315112.
Antioxidants (Basel). 2020 Jun 3;9(6):485. doi: 10.3390/antiox9060485.
4
Vitamin D and Muscle Sarcopenia in Aging.维生素 D 与衰老相关的肌肉减少症。
Methods Mol Biol. 2020;2138:29-47. doi: 10.1007/978-1-0716-0471-7_2.
5
New aspects of vitamin D metabolism and action - addressing the skin as source and target.维生素 D 代谢和作用的新方面 - 关注皮肤作为来源和靶点。
Nat Rev Endocrinol. 2020 Apr;16(4):234-252. doi: 10.1038/s41574-019-0312-5. Epub 2020 Feb 6.
6
Ethosomes for Dermal Administration of Natural Active Molecules.透皮给药用醇质体传递系统:天然活性分子
Curr Pharm Des. 2019;25(21):2338-2348. doi: 10.2174/1381612825666190716095826.
7
Liposomal Vitamin D as an Anti-aging Agent for the Skin.脂质体维生素D作为皮肤抗老化剂
Pharmaceutics. 2019 Jul 3;11(7):311. doi: 10.3390/pharmaceutics11070311.
8
Embedding cell monolayers to investigate nanoparticle-plasmalemma interactions at transmission electron microscopy.嵌入细胞单层以在透射电子显微镜下研究纳米颗粒与质膜的相互作用。
Eur J Histochem. 2019 Mar 28;63(1):3026. doi: 10.4081/ejh.2019.3026.
9
Uptake and intracellular distribution of different types of nanoparticles in primary human myoblasts and myotubes.不同类型纳米颗粒在原代人肌母细胞和肌管中的摄取和细胞内分布。
Int J Pharm. 2019 Apr 5;560:347-356. doi: 10.1016/j.ijpharm.2019.02.017. Epub 2019 Feb 20.
10
Uptake and intracellular fate of biocompatible nanocarriers in cycling and noncycling cells.生物相容纳米载体在循环和非循环细胞中的摄取和细胞内命运。
Nanomedicine (Lond). 2019 Feb;14(3):301-316. doi: 10.2217/nnm-2018-0148. Epub 2019 Jan 22.